Verona Pharma has started the second part of a Phase 2 trial evaluating its investigational therapy ensifentrine (RPL544) in patients in the U.K. with moderate to severe chronic obstructive pulmonary disease (COPD), following delays related to COVID-19, the company announced in a press release. Part…
News
Researchers at Washington University School of Medicine in St. Louis have been awarded $3.9 million in funding to continue developing a treatment candidate that reduces mucus production and inflammation in debilitating lung diseases, such as chronic obstructive pulmonary disease (COPD) and asthma. The award from the…
PR1P, a small peptide able to increase the activity of vascular endothelial growth factor (VEGF) in cells lining the inside of blood vessels, can reduce lung cell death and tissue damage in a mouse model of emphysema, a study reports. According to investigators, these findings highlight the therapeutic…
Adhering to a healthy diet — be it a Mediterranean diet, a prudent diet, or a diet supported by health associations — significantly lowers the risk of chronic obstructive pulmonary disease (COPD), a recent meta-analysis suggests. Unhealthy diets, such as the Western diet, appear to…
To help people experiencing the lingering effects of coronavirus infection, the Pulmonary Wellness Foundation (PWF) has launched a free online rehabilitation and recovery program called COVID Bootcamp 101. In addition to patient education and support, the program offers breathing and other exercises conducted by a team of…
AstraZeneca‘s Breztri Aerosphere has been approved by the U.S. Food and Drug Administration (FDA) as a maintenance treatment for chronic obstructive pulmonary disease (COPD). Formerly known as PT010, Breztri Aerosphere is an inhaled therapy with three active components: the long-acting muscarinic antagonist…
Patients with chronic obstructive pulmonary disease (COPD) should be more cautious when taking metformin, a common medication used to treat diabetes. In patients with both COPD and type 2 diabetes mellitus (T2DM), metformin carries a higher risk for pneumonia, hospitalization for COPD, and invasive mechanical ventilation. This…
Younger patients report feeling a heavier burden and greater daily impact from the symptoms of chronic obstructive pulmonary disease (COPD) than older patients, a global survey has revealed. Physicians should thus optimize treatment for these younger patients, say researchers leading the survey. The findings were published in an article,…
The ProAir Digihaler, a digital inhaler designed for people with asthma and chronic obstructive pulmonary disease (COPD) to monitor their inhaler usage through the use of a mobile app, is now available by prescription in the U.S. The albuterol inhaler (albuterol sulfate, 117 micrograms), developed by Teva…
Chronic obstructive pulmonary disease (COPD) appears to be a risk factor for lung cancer, liver cancer, and colorectal cancer, regardless of smoking status, a data study from Korea reported. The study, “Cancer development in patients with COPD: a retrospective analysis of the National Health Insurance Service-National…
Recent Posts
- Living with COPD isn’t a test that I have to pass February 10, 2026
- Mucus-based test shows promise for measuring health of lungs in COPD February 4, 2026
- After a trifecta of illness, I’m again breathing without thinking about it February 3, 2026
- Getting better with COPD means doing the work the way our ancestors did January 27, 2026
- A tip on oxygen concentrator maintenance: Try ‘blowing the drip’ January 20, 2026
- When it came to ‘quilting’ my lungs, I chose lifestyle seams over pleurodesis January 13, 2026
- New COPD trial doses first participant with dual-target drug BBT002 January 7, 2026
- What an old racehorse taught me about being first with COPD January 6, 2026
- A kitchen memory holds a lesson about tenderness while living with COPD December 23, 2025
- What a cat and a kangaroo mouse taught me about living with COPD December 16, 2025